JAPANESE ENCEPHALITIS VACCINE 1mL Malasia - inglés - NPRA (National Pharmaceutical Regulatory Agency, Bahagian Regulatori Farmasi Negara)

japanese encephalitis vaccine 1ml

propharm (m) sdn. bhd. - inactivated japanese encephalitis vacci* -

STAMARIL YELLOW FEVER VACCINE 1000 Suspension for Injection Irlanda - inglés - HPRA (Health Products Regulatory Authority)

stamaril yellow fever vaccine 1000 suspension for injection

sanofi pasteur msd ltd - yellow fever virus 17 d-204 strain - suspension for injection - 1000 - yellow fever vaccines

TICOVAC 0.5 ML %v/v Suspension for Injection Irlanda - inglés - HPRA (Health Products Regulatory Authority)

ticovac 0.5 ml %v/v suspension for injection

baxter vaccine ag - tbe virus antigen - suspension for injection - %v/v

TICOVAC JUNIOR 0.25 ML %v/v Suspension for Injection Irlanda - inglés - HPRA (Health Products Regulatory Authority)

ticovac junior 0.25 ml %v/v suspension for injection

baxter vaccine ag - tbe virus antigen - suspension for injection - %v/v

VAQTA VACCINE 50Uml Singapur - inglés - HSA (Health Sciences Authority)

vaqta vaccine 50uml

msd pharma (singapore) pte. ltd. - hepatitis a virus (inactivated) - injection - 50u/ml - hepatitis a virus (inactivated) 50u/ml

VAQTA VACCINE 25 u0.5 ml Singapur - inglés - HSA (Health Sciences Authority)

vaqta vaccine 25 u0.5 ml

msd pharma (singapore) pte. ltd. - hepatitis a virus (inactivated) - injection - 25 u/0.5 ml - hepatitis a virus (inactivated) 25 u/0.5 ml

Stamaril vaccine powder and solvent for suspension for injection 0.5ml vials Reino Unido - inglés - MHRA (Medicines & Healthcare Products Regulatory Agency)

stamaril vaccine powder and solvent for suspension for injection 0.5ml vials

sanofi - yellow fever virus strain 17d - powder and solvent for suspension for injection

IXIARO- japanese encephalitis vaccine, inactivated, adsorbed injection, suspension Estados Unidos - inglés - NLM (National Library of Medicine)

ixiaro- japanese encephalitis vaccine, inactivated, adsorbed injection, suspension

valneva scotland ltd. - japanese encephalitis virus strain sa 14-14-2 antigen (formaldehyde inactivated) (unii: dz854i04ze) (japanese encephalitis virus strain sa 14-14-2 antigen (formaldehyde inactivated) - unii:dz854i04ze) - ixiaro is a vaccine indicated for the prevention of disease caused by japanese encephalitis virus (jev). ixiaro is approved for use in individuals 2 months of age and older. severe allergic reaction (e.g., anaphylaxis) after a previous dose of ixiaro, any other japanese encephalitis virus vaccine, or any component of ixiaro, including protamine sulfate, is a contraindication to administration of ixiaro [see description (11)]. alternatively, because of uncertainty as to which component of the vaccine may be responsible, individuals with a history of severe allergic reaction to another japanese encephalitis vaccine may be referred to an allergist for evaluation if immunization with ixiaro is considered. pregnancy category b. reproduction studies have been performed in female rats at doses approximately 300-fold excess relative to the projected human dose (on a mg/kg basis) and have revealed no evidence of impaired fertility or harm to the fetus due to ixiaro. there are, however, no adequate and well‑controlled

VAXCHORA POWDER FOR SUSPENSION Canadá - inglés - Health Canada

vaxchora powder for suspension

bavarian nordic as - vibrio cholerae, strain cvd 103-hgr, live - powder for suspension - 2000000000unit - vibrio cholerae, strain cvd 103-hgr, live 2000000000unit

FSME-IMMUN SUSPENSION Canadá - inglés - Health Canada

fsme-immun suspension

baxter corporation - tick-borne encephalitis vaccine (inactivated) - suspension - 2.4mcg - tick-borne encephalitis vaccine (inactivated) 2.4mcg - vaccines